Dendrite International announces expansion of Glaxo contract as a result of merger with Welcome.MORRISTOWN, N.J.--(BUSINESS WIRE)--Oct. 26, 1995--Dendrite International Inc. (NASDAQ/NMS:DRTE DRTE Defence Research Telecommunications Establishment ) today announced that its contract for worldwide pharmaceutical giant Glaxo's Belgian operations has been expanded to incorporate the recent merger with Welcome. The inclusion of the Welcome sales force represents an increase of approximately 20% in the size of the original agreement for the Belgian territory. Glaxo is licensing Dendrite's industry-leading sales force automation Automating the sales activities within an organization. A comprehensive SFA package provides such functions as contact management, note and information sharing, quick proposal and presentation generation, product configurators, calendars and to-do lists. solution on an annual basis. Dendrite dendrite: see nervous system; synapse. also provides facilities management services. Dendrite International provides comprehensive Electronic Territory Management (ETM (database) ETM - An active DBMS from the University of Karlsruhe. ) solutions used to manage, coordinate and control the activities of large sales organizations in complex selling environments. Since its founding in 1987, Dendrite has focused primarily on pharmaceutical and healthcare clients worldwide, and it has become the largest global provider of electronic management software and related services to these industries. Headquartered in Morristown, Dendrite has offices throughout the United States, six in Western Europe, Japan, Australia and New Zealand New Zealand (zē`lənd), island country (2005 est. pop. 4,035,000), 104,454 sq mi (270,534 sq km), in the S Pacific Ocean, over 1,000 mi (1,600 km) SE of Australia. The capital is Wellington; the largest city and leading port is Auckland. . CONTACT: John Bailye 201/425-2111 or Charles Warczakowski, 201/425-2115 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion